ISS Endorses Titan Medical's Merger with Conavi for Growth

Titan Medical Gains Support for Amalgamation with Conavi

Titan Medical Inc. (TSX: TMD; OTC: TMDIF) is thrilled to share that the independent proxy advisory firm, Institutional Shareholder Services (ISS), has issued a recommendation for its shareholders to vote in favor of the proposed amalgamation with Conavi Medical Inc. This significant endorsement comes ahead of the crucial meeting for Titan shareholders scheduled for late September.

Importance of the Recommendation

ISS plays a vital role in guiding many prominent institutional investors with over 3,400 clients globally. They provide an objective and thorough analysis that helps these investors make well-informed voting decisions. Their recommendation is centered on the belief that the amalgamation presents a strategic opportunity for Titan, indicating it is a favorable choice for enhancing shareholder value.

Strategic Growth Opportunities

According to the ISS report, the amalgamation stands out as a robust alternative to ensure the continuous growth and improvement of Titan’s potential value. The anticipated partnership is seen as an opportunity that not only augments Titan's financial stability but also positions it to capitalize on reducing listing requirements on the TSX Venture Exchange (TSXV).

CEO’s Statement on ISS Endorsement

In response to the recommendation, Paul Cataford, Titan’s Interim CEO and Board Chairman, expressed his satisfaction, noting, "We are pleased that after reviewing the proposed business combination, ISS is recommending all shareholders vote for the Amalgamation. This independent analysis and recommendation validate our board’s unanimous decision to support the transaction with Conavi Medical Inc."

Voting Process and Shareholder Engagement

Titan urges shareholders not to delay in casting their votes, emphasizing the importance of every vote, regardless of the number of shares owned. The deadline for voting is set for September 26 at 4:00 PM Eastern Time.

Support for Shareholder Queries

Shareholders requiring assistance or having questions about the meeting and voting process can reach out to the Shorecrest Group. They are available via telephone at 1-888-637-5789 or +1-647-931-7454 for those calling from outside North America, and through email.

About Titan Medical Inc.

Titan Medical Inc. is a cutting-edge medical technology company incorporated under the Business Corporations Act (Ontario) and based in Toronto. Titan has developed an extensive patent portfolio aimed at advancing robotic-assisted surgery (RAS), emphasizing innovation through a single access point. The company continually seeks opportunities to enhance and license its intellectual property.

Overview of Conavi Medical

Conavi Medical Inc. specializes in creating imaging technologies for minimally invasive cardiovascular procedures. Their flagship product, the Novasight Hybrid™ System, innovatively combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT), securing regulatory approvals for clinical use in various markets, including the U.S. and Canada.

Frequently Asked Questions

What is the ISS recommendation regarding Titan Medical's amalgamation?

ISS recommends that Titan Medical shareholders vote in favor of the amalgamation with Conavi Medical, indicating it as a strategic opportunity for value enhancement.

Why is the amalgamation considered beneficial for shareholders?

The amalgamation is viewed as a key move to improve shareholder value, offering enhanced financial stability and growth opportunities.

When is the voting deadline for shareholders?

The deadline for Titan shareholders to cast their votes is September 26 at 4:00 PM Eastern Time.

How can shareholders seek assistance with the voting process?

Shareholders can contact Shorecrest Group by phone or email for any queries or assistance regarding the meeting and voting procedures.

What does Titan Medical focus on as a company?

Titan Medical focuses on developing innovative robotic-assisted surgery technologies and seeks to enhance and license its considerable intellectual property portfolio.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.